Consistently, an increasing number of studies have detected cytotoxic CD4+ T cells in various conditions, including acute viral infections, anti-tumor responses in human cancer patients, and chronic inflammatory responses in autoimmune diseases [54,81,82], posing important questions as to their biological and clinical relevance. Here, CD4 is linked to cancer.